Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase-Reference-Cited by-同舟云学术

Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase

Published:2013-10-15 Issue:2 Volume:35 Page:272-281
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Chuma Makoto,Sakamoto Naoya,Nakai Akira,Hige Shuhei,Nakanishi Mitsuru,Natsuizaka Mitsuteru,Suda Goki,Sho Takuya,Hatanaka Kanako,Matsuno Yoshihiro,Yokoo Hideki,Kamiyama Toshiya,Taketomi Akinobu,Fujii Gen,Tashiro Kosuke,Hikiba Yoko,Fujimoto Mitsuaki,Asaka Masahiro,Maeda Shin

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/35/2/272/17293821/bgt343.pdf

Reference43 articles.

1. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology,(2012)

2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol.,(2009)

3. Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches;Breuhahn;Hepatology,(2011)

4. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond;Pirkkala;FASEB J.,(2001)

5. Heat shock factor and the heat shock response;Sorger;Cell,(1991)

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma;Journal of Experimental & Clinical Cancer Research;2024-09-06

2. MYC and HSF1 Cooperate to Drive PLK1 inhibitor Sensitivity in High Grade Serous Ovarian Cancer;2024-06-13

3. Driving proteomic imbalance to combat Neurofibromatosis type I (NF1)-associated malignancy;2024-05-27

4. Predictive value of immediate early response 5 like (IER5L) in the prognosis and immune checkpoint blockade therapy of non-small cell lung cancer patients;Pathology - Research and Practice;2024-04

5. Targeting the heat shock response induced by modulated electro-hyperthermia (mEHT) in cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03